Bempedoic Acid: A New Drug for an Old Problem.
Dat NguyenNathan DuElisabeth M SulaicaMatthew A WanatPublished in: The Annals of pharmacotherapy (2020)
The recent FDA approval of bempedoic acid offers an additional option for lowering LDL-C levels in patients with atherosclerotic cardiovascular disease or heterozygous familial hyperlipidemia. Additional data regarding effect on long-term cardiovascular outcomes with bempedoic acid are currently being studied.